A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
Public ClinicalTrials.gov record NCT06531395. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Primary objective of the study is to evaluate the effect of abiprubart on an established systemic disease activity measure for Sjögren's Disease.
Study identification
- NCT ID
- NCT06531395
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 3 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 17, 2024 (Actual)
- Primary completion
- Mar 6, 2025 (Actual)
- Completion
- May 1, 2025 (Actual)
- Last update posted
- May 21, 2025
2024 – 2025
United States locations
- U.S. sites
- 16
- U.S. states
- 6
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medvin Clinical Research | Menifee | California | 92586 | — |
| BioSolutions Clinical Research Center | Poway | California | 92064 | — |
| Medvin Clinical Research | Whittier | California | 90602 | — |
| International Medical Research | Daytona Beach | Florida | 32117 | — |
| Omega Research Debary, LLC | DeBary | Florida | 32713 | — |
| Greater Chicago Specialty Physicians/ Clinical Investigation Specialists | Schaumburg | Illinois | 60195 | — |
| Clinic of Robert Hozman, MD/Clinical Investigation Specialists, Inc. | Skokie | Illinois | 60076 | — |
| Springfield Clinic Rheumatology | Springfield | Illinois | 62702 | — |
| Accurate Clinical Research, Inc | Lake Charles | Louisiana | 70605 | — |
| Accellacare (Salisbury) | Salisbury | North Carolina | 28144 | — |
| Carolina Arthritis Associates | Wilmington | North Carolina | 28401 | — |
| Arthritis and Rheumatology Research Institute, PLLC | Allen | Texas | 75013 | — |
| Arthritis Care of Texas | Corpus Christi | Texas | 78415 | — |
| Trinity Universal Research Associates, Inc. | Plano | Texas | 75024 | — |
| Sun Research Institute | San Antonio | Texas | 78215 | — |
| Arthritis & Osteoporosis Clinic | Waco | Texas | 76710 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06531395, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 21, 2025 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06531395 live on ClinicalTrials.gov.